DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer

NCT00603460 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cancer

Interventions

BIOLOGICAL: DCVax-L and T Cells

Sponsor

University of Pennsylvania

Collaborators

[object Object]